Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Oruka Therapeutics, Inc (ORKA)  
$11.21 0.13 (1.17%) as of 4:30 Mon 6/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 34,998,000
Market Cap: 392.33(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.78 - $30.49
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 13
Insider 3/6 Months : 13.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year    
 
Company Profile   ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 122,882 757,560 757,560
Total Buy Value $0 $1,407,368 $3,550,945 $3,550,945
Total People Bought 0 1 2 2
Total Buy Transactions 0 5 14 14
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 107
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shah Nimish P 10% Owner   –       –       •   2025-02-14 4 B $11.44 $1,015,803 I/I 88,794 4,148,428 1.5 4%     
   Shah Nimish P 10% Owner   –       –       •   2025-02-13 4 B $11.63 $173,869 I/I 14,950 4,059,634 1.5 2%     
   Shah Nimish P 10% Owner   –       –       •   2025-02-12 4 B $11.86 $106,396 I/I 8,971 4,044,684 1.5 -1%     
   Shah Nimish P 10% Owner   –       –       •   2025-02-11 4 B $10.95 $105,043 I/I 9,593 4,035,713 1.5 -1%     
   Shah Nimish P 10% Owner   –       –       •   2025-02-10 3 IO $0.00 $0 I/I 0 4,025,546 7%     
   Shah Nimish P 10% Owner   –       –       •   2025-02-10 4 B $10.90 $6,257 I/I 574 4,026,120 1.5 7%     
   Harwin Peter Evan Director   –       •       •   2024-11-19 4 OE $0.00 $0 I/I 160,000 798,614     -
   Harwin Peter Evan Director   –       •       •   2024-09-11 4 A $23.00 $6,325,000 I/I 275,000 638,614     -
   Klein Lawrence Otto President and CEOOfficer   •       •      –    2024-08-29 3 IO $0.00 $0 D/D 0 852,338     -
   Turtle Cameron Director   –       •      –    2024-08-29 3 IO $0.00 $0 I/I 0 85,233     -
   Harwin Peter Evan Director   –       •       •   2024-08-29 3 IO $0.00 $0 I/I 0 2,936,922     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-08-16 4 B $2.93 $17,067 I/I 5,818 2,117,213 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-25 4 B $3.05 $92,292 I/I 30,227 2,111,395 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-24 4 B $3.16 $606,873 I/I 189,856 2,081,168 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-11 4 B $3.45 $326,304 I/I 94,537 1,891,312 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-10 4 B $3.46 $192,130 I/I 55,463 1,796,775 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-09 4 B $3.43 $58,091 I/I 16,917 1,741,312 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-08 4 B $3.41 $164,190 I/I 47,492 1,724,395 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-05 4 B $3.41 $97,065 I/I 28,326 1,676,903 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   •       •       •   2024-07-03 4 B $3.55 $589,565 I/I 166,042 1,648,577 1.5     -
   Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner   –       –       •   2024-07-02 3 IO $0.00 $0 I/I 0 1,482,535     -
   Ma-Weaver Jacob See Footnote 1   –       •       •   2022-12-16 4 OE $2.50 $3,550,000 D/D 1,420,000 4,000,452     -
   Keuer Thomas A Chief Operating Officer   •       –      –    2022-12-08 4 A $0.00 $0 D/D 40,000 40,730     -
   Dekker C. Jeffrey Chief Financial Officer   •       –      –    2022-12-08 4 A $0.00 $0 D/D 40,000 40,000     -
   Funicular Funds, Lp 10% Owner   –       –       •   2022-07-01 3 IO $0.00 $0 I/I 0 2,580,452     -
  107 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us